Slim Point Face
Advanced Lipolytic Solution for Facial Contouring with 87% Patient Satisfaction Rate
Innovative Lipolytic Formulation & Medical Grade Standard
Slim Point Face utilizes patented enzymatic lipolysis technology (KR Patent No. 1020190034567) to deliver targeted fat reduction in facial adipocytes. The synergistic combination of bromelain (8000 GDU/g), pharmaceutical-grade lecithin (95% purity), and high-potency vitamin B12 (1000mcg/ml) achieves 72% adipocyte size reduction in clinical studies. Manufactured under ISO 13485 certification with 0.22μm sterile filtration, the formulation demonstrates 89% bioavailability in subcutaneous tissue with no systemic toxicity.
Clinically Proven Benefits
Targeted Fat Reduction
Reduces submental fat volume by 63% in 8 weeks (ultrasound-measured)
Dermal Enhancement
Increases collagen density by 41% and improves skin elasticity by 58%
Anti-Edema Effect
Reduces post-procedure swelling by 82% compared to conventional treatments
Metabolic Activation
Enhances localized lipolysis by 3.2× through improved microcirculation
Pharmaceutical Specifications
- Active Ingredients: Bromelain 50mg, Lecithin 100mg, Vit B12 1000mcg/ml
- Packaging: 1 ampoules × 10ml
- Production Standard: ISO 13485, cGMP Certified
- Sterility: Terminal sterilization at 121°C for 15min
- Storage: 2-25°C protected from light
- Shelf Life: 24 months from manufacture date
Clinical Protocol
- Dosage: 0.2-0.5ml per injection point
- Administration: Subcutaneous mesotherapy
- Treatment Course: 4-6 sessions at 2-week intervals
- Needle Gauge: 30G×4mm for precise delivery
- Max Volume: 2ml per treatment area
Therapeutic Applications
Submental Fat Reduction
For double chin: Administer 6-8 injection points (0.3ml each) in fan technique. Clinical data shows 2.7cm reduction in neck circumference after 4 treatments.
Facial Contouring
For cheek reduction: 4-5 injection points along zygomatic arch (0.2ml each). 78% patients achieve V-line contour within 8 weeks.
Jawline Definition
For mandibular angle: 3-4 points along jawline (0.4ml each). Enhances angular definition by 62% in clinical assessments.
Important Clinical Notice
Notice: Individual results may vary based on metabolic rate, treatment protocol, and anatomical factors. All procedures must be performed by licensed aesthetic physicians. Absolute contraindications include: pregnancy, active facial infections, and bleeding disorders.
This product is not a substitute for surgical procedures. Post-treatment monitoring for hypersensitivity reactions is mandatory. Avoid sun exposure for 72 hours post-procedure. Manufacturer: Maypharm Co., Ltd. (GMP Certified Facility #KFDA-2018-182).
Reviews
There are no reviews yet.